Cemiplimab as Maintenance Treatment for Advanced Adrenocortical Cancer

NCT07085572 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Adrenal Cortical Carcinoma

Interventions

DRUG: Cemiplimab

Sponsor

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia